Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 806 results for "avp research"

Buy silver natural gas; sell zinc: Navneet Damani

Watch the interview of Navneet Damani, AVP Commodities Currency Research at Motilal Oswal Commodities with Ekta Batra and Reema Tendulkar on CNBC-TV18. He spoke about the current trend in commodities markets. Money Control, 1 week ago

3 images for "avp research"

Mideast Time, 5 days ago
American Banking News, 5 days ago
Silicon India, 3 weeks ago

Hindalco underperformance due to interest cost rise: IIFL

Reacting to the Hindalco numbers, Tarang Bhanushali, AVP- Research, IIFL says the underperformance is largely due to a jump in interest cost which has come due to commissioning of new capacities during the quarter.
 Money Control2 weeks ago

Bajaj Auto Q1 weak; analyst say volumes may not fall ahead

Prayesh Jain, AVP- Research Analyst, IIFL expected the auto player to post EBITDA of around Rs 1024 crore but the company disappointed by posting just Rs 925 crore. We were expecting the margins to be over 19.8 percent given the company's exports ...
 Moneycontrol.com1 month ago
American Banking News

Research Analysts Ratings Reiterations for August, 27th (ABM, ADI, AEE, AGU, AVP, C, CBSH, COO, CZZ, DF)

Research Analysts ratings reiterations for Wednesday, August 27th: ABM Industries (NYSE:ABM) Analog Devices (NYSE:ADI) Ameren Corp (NYSE:AEE) Agrium (NYSE:AGU) Avon Products (NYSE:AVP) Citigroup (NYSE:C) Commerce Bancshares ...
 American Banking News5 days ago

Avon Products Given New $14.00 Price Target at Wedbush (AVP)

Investment analysts at Wedbush lowered their target price on shares of Avon Products (NYSE:AVP) Other equities research analysts have also recently issued reports about the stock. Analysts at Bernstein raised their price target on shares of Avon ...
 American Banking News1 month ago Avon Products Price Target Lowered to $14.00 at BMO Capital Markets (AVP)  American Banking News3 weeks ago Short Interest in Avon Products Rises By 40.4% (AVP)  American Banking News2 weeks ago Avon Products PT Raised to $16.00 (AVP)  American Banking News1 month ago

Avanir Doses First Patient with AVP-786, Updates on AVP-923

Avanir Pharmaceuticals, Inc. ( AVNR ) announced that it has enrolled the first patient in a phase II study on AVP-786 for the adjunctive treatment of major depressive disorder ( MDD ). The company also provided an update on a phase II study on ...
 Yahoo! Finance5 days ago Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder  Financial Content1 week ago
European Pharmaceutical Manufacturer

Concert Pharma secures $2m payment for new drug product AVP-786

Concert Pharmaceuticals has received a $2m milestone as part of a development and license agreement with Avanir Pharmaceuticals for the clinical progression of AVP-786 in patients with major depressive disorder (MDD). The new drug product, AVP-786, ...
 Pharmaceutical Business Review6 days ago Concert Pharmaceuticals Achieves $2 Million Milestone for AVP-786 Under Avanir Pharmaceuticals Collaboration  Business Wire1 week ago Concert Pharmaceuticals, Inc. Achieves $2 Million Milestone For AVP-786 Under AVANIR Pharmaceuticals Collaboration  BioSpace6 days ago CONCERT PHARMACEUTICALS : Achieves $2 Million Milestone for AVP-786 Under Avanir Pharmaceuticals Collaboration  4 Traders1 week ago

Global Biopesticides Industry

]]> NEW YORK , Aug. 12, 2014 /PRNewswire/ -- announces that a new market research report is available in its catalogue: This report analyzes the ...
 Sys-Con Italia3 weeks ago Alzheimer%s Disease Global Clinical Trials Review, H1, 2014  TickerTech.com1 month ago The Global Cosmetics Industry: Leading Innovation  Bidness Etc1 month ago

Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for Major Depressive Disorder

/PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the U.S. Food and Drug Administration (FDA) accepted the company's Investigational New Drug (IND) application for a Phase II study assessing the safety and efficacy of ...
 Drugs.com1 month ago Avanir's IND for AVP-786 for treatment of MDD receives FDA acceptance  Individual.com1 month ago Avanir Pharmaceuticals Receives FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder  Pharmaceutical & Medical Packaging News1 month ago Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update  Financial Content3 weeks ago
Yahoo! Finance

For The First Time Ever, The Epic Battle of "AVP: Alien vs. Predator" Becomes Reality at Universal Orlando …

ORLANDO, Fla. andUNIVERSAL CITY, Calif., Aug. 5, 2014 /PRNewswire/ --In collaboration with Twentieth Century Fox Consumer Products, Universal Orlando Resort and Universal Studios Hollywood are putting "Halloween Horror Nights'" guests in the middle ...
 Yahoo! Finance3 weeks ago Alien Vs Predator Announced For Universal's Halloween Horror Nights  411mania.com3 weeks ago 10Best Reveal: Alien vs. Predator at Universal's HHN  USA Today4 weeks ago Aalto University among the five rising stars of the world's leading universities, says MIT study  Science Business1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less